07/ 11/ 2026
NMPA Clarifies Four Priority Review Scenarios for Chemical APIs, Effective August 1, 2026
NMPA's July 2026 announcement specifies four scenarios for chemical API priority review, effective 1 August.
07/ 10/ 2026
Bestcomm Ranked in Top 50 Pharmaceutical R&D Companies In China
Bestcomm won "Independent Innovation Enterprise" and "Top 50 R&D Company" at the 2025–2026 Industry Conference.
07/ 03/ 2026
ICH Releases E6(R3) Annex 2: Clinical Trial Quality Management Enters the Era of "Decentralised + Real-World Data"
ICH E6(R3) Annex 2 provides GCP guidance for decentralised, pragmatic, and RWD‑enriched trials. It emphasises proportionality, QbD, patient engagement, and early regulator dialogue, reshaping clinical trial quality management for the digital era.
